| 2022-05-25 | Gain Therapeutics, Inc. GANX | CHIEF EXECUTIVE OFFICER | 2,482 0.0203% | $2.58 | $6,404 | +43.21% | ||
| 2022-05-19 | Gain Therapeutics, Inc. GANX | CHIEF EXECUTIVE OFFICER | 9,256 0.0816% | $2.83 | $26,194 | +39.63% | ||
| 2021-08-16 | Gain Therapeutics, Inc. GANX | Chief Executive Officer | 4,922 0.042% | $7.87 | $38,716 | -45.68% | ||
| 2018-06-08 | ADMA Biologics, Inc. ADMA | director | 5,230 0.0123% | $4.78 | $24,999 | +1.05% | ||
| 2017-11-09 | ADMA Biologics, Inc. ADMA | director | 25,000 0.0494% | $2.15 | $53,750 | +103.33% | ||
| 2016-04-13 | Sale | Altimmune, Inc. ALT | director | 88,233 5.0849% | $2.13 | $188,290 | +26.13% | |
| 2016-04-08 | Sale | Altimmune, Inc. ALT | director | 12,800 0.7889% | $2.20 | $28,160 | +30.84% | |
| 2016-04-07 | Sale | Altimmune, Inc. ALT | director | 5,367 0.2574% | $1.76 | $9,446 | +27.27% | |
| 2015-03-13 | ADMA Biologics, Inc. ADMA | director | 7,000 0.0722% | $7.88 | $55,140 | +14.84% | ||
| 2011-11-10 | Altimmune, Inc. ALT | President and CEO | 20,000 0.0013% | $1.50 | $30,050 | +0.22% | ||
| 2010-06-17 | Altimmune, Inc. ALT | President and Interim CEO | 20,000 0.0021% | $1.58 | $31,534 | +1.05% |